DK0425154T3 - Genstande med vedvarende afgivelse af aktivt stof - Google Patents

Genstande med vedvarende afgivelse af aktivt stof

Info

Publication number
DK0425154T3
DK0425154T3 DK90311278.7T DK90311278T DK0425154T3 DK 0425154 T3 DK0425154 T3 DK 0425154T3 DK 90311278 T DK90311278 T DK 90311278T DK 0425154 T3 DK0425154 T3 DK 0425154T3
Authority
DK
Denmark
Prior art keywords
items
active substance
sustained release
sustained
release
Prior art date
Application number
DK90311278.7T
Other languages
English (en)
Inventor
Louis Michel Jaques Aguadisch
Bernard Francis Grisoni
Alain Etienne
Original Assignee
Dow Corning Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Corning Sa filed Critical Dow Corning Sa
Application granted granted Critical
Publication of DK0425154T3 publication Critical patent/DK0425154T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/2036—Silicones; Polysiloxanes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK90311278.7T 1989-10-23 1990-10-16 Genstande med vedvarende afgivelse af aktivt stof DK0425154T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8913818A FR2653337B1 (fr) 1989-10-23 1989-10-23 Element a liberation prolongee et procede pour le fabriquer.

Publications (1)

Publication Number Publication Date
DK0425154T3 true DK0425154T3 (da) 1993-11-01

Family

ID=9386646

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90311278.7T DK0425154T3 (da) 1989-10-23 1990-10-16 Genstande med vedvarende afgivelse af aktivt stof

Country Status (13)

Country Link
EP (1) EP0425154B1 (da)
JP (1) JPH03167116A (da)
KR (1) KR910007518A (da)
AU (1) AU639947B2 (da)
BR (1) BR9005223A (da)
CA (1) CA2027865A1 (da)
DE (1) DE69003347T2 (da)
DK (1) DK0425154T3 (da)
ES (1) ES2044451T3 (da)
FI (1) FI905195A0 (da)
FR (1) FR2653337B1 (da)
HU (1) HUT69395A (da)
IE (1) IE66826B1 (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208233A (en) * 1989-09-15 1993-05-04 The United States Of America As Represented By The Department Of Health And Human Services Anti-hypertensive compositions of secondary amine-nitric oxide adducts and use thereof
US5721365A (en) * 1989-09-15 1998-02-24 Us Health N-substituted piperazine NONOates
FR2677253A1 (fr) * 1991-06-07 1992-12-11 Union Metropolitaine Pharmaceu Composition therapeutique utile vis-a-vis des maladies inflammatoires du systeme gastro-intestinal.
AU668107B2 (en) * 1991-09-24 1996-04-26 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Oxygen substituted derivatives of nucleophile-nitric oxide adducts as nitric oxide donor prodrugs
US5910316A (en) 1992-08-24 1999-06-08 The United States Of America, As Represented By The Department Of Health And Human Services Use of nitric oxide-releasing agents to treat impotency
US6200558B1 (en) 1993-09-14 2001-03-13 The United States Of America As Represented By The Department Of Health And Human Services Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
US5691423A (en) * 1992-08-24 1997-11-25 The United States Of America As Represented By The Department Of Health And Human Services Polysaccharide-bound nitric oxide-nucleophile adducts
US5525357A (en) * 1992-08-24 1996-06-11 The United States Of America As Represented By The Department Of Health And Human Services Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
US5405919A (en) * 1992-08-24 1995-04-11 The United States Of America As Represented By The Secretary Of Health And Human Services Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions and methods of treating biological disorders
US5714511A (en) * 1995-07-31 1998-02-03 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Selective prevention of organ injury in sepsis and shock using selection release of nitric oxide in vulnerable organs
FR2752380B1 (fr) * 1996-08-14 1998-10-30 Dow Corning Sa Procede de fabrication d'un dispositif a liberation controlee
US6261594B1 (en) 1998-11-25 2001-07-17 The University Of Akron Chitosan-based nitric oxide donor compositions
US6723342B1 (en) 1999-02-08 2004-04-20 Fmc Corporation Edible coating composition
US6432448B1 (en) 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
US6500462B1 (en) 1999-10-29 2002-12-31 Fmc Corporation Edible MCC/PGA coating composition
TR200300731T2 (tr) 2000-11-28 2004-08-23 Fmc Corporation Yenebilir PGA kaplama bileşimi
KR100477364B1 (ko) * 2002-07-03 2005-03-22 주식회사 메디켐스 신규한 헬리코박터 파이로리 균 진단용 13ｃ-요소 캅셀 제제
AR040682A1 (es) 2002-07-25 2005-04-13 Pharmacia Corp Forma de dosificacion una vez al dia de pramipexol
SG164375A1 (en) 2004-08-13 2010-09-29 Boehringer Ingelheim Int Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
EP2135602A1 (en) 2004-08-13 2009-12-23 Boehringer Ingelheim International GmbH Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
ATE396710T1 (de) * 2005-07-19 2008-06-15 Ethypharm Sa Gastroretentive zusammensetzungen und verfahren zur herstellung
WO2007086078A2 (en) * 2006-01-30 2007-08-02 Panacea Biotec Ltd. Novel pharmaceutical compositions and process of preparation thereof
GB0909680D0 (en) 2009-06-05 2009-07-22 Euro Celtique Sa Dosage form
EP3738619A1 (en) * 2010-04-14 2020-11-18 Mölnlycke Health Care AB Antimicrobial gels
NZ700732A (en) 2010-05-10 2015-08-28 Euro Celtique Sa Pharmaceutical compositions comprising hydromorphone and naloxone
CA2798884C (en) 2010-05-10 2016-09-13 Euro-Celtique S.A. Manufacturing of active-free granules and tablets comprising the same
AU2011252041B2 (en) 2010-05-10 2014-04-03 Euro-Celtique S.A. Combination of active loaded granules with additional actives
GB201020895D0 (en) 2010-12-09 2011-01-26 Euro Celtique Sa Dosage form
EA030310B1 (ru) 2013-11-13 2018-07-31 Эро-Селтик С.А. Гидроморфон и налоксон для лечения боли и индуцированного опиоидами синдрома дисфункции кишечника
KR101599126B1 (ko) 2014-04-01 2016-03-14 주식회사 명성 스크루식 뚜껑 성형장치
US11529310B2 (en) 2020-12-08 2022-12-20 Ruminant Biotech Corp Limited Devices and methods for delivery of substances to animals
WO2023148315A1 (en) * 2022-02-03 2023-08-10 Basf Se Potassium-sodium tartrate as granulating aid

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE791632A (fr) * 1971-11-20 1973-05-21 Schering Ag Supports a base de caoutchouc siliconique pour agents medicamenteux
US3991750A (en) * 1975-04-28 1976-11-16 Syntex Corporation Dromostanolone propionate implant pellet useful for producing weight gains in animals and suppressing estrus in female animals
SE8203953D0 (sv) * 1982-06-24 1982-06-24 Astra Laekemedel Ab Pharmaceutical mixture
CA1331338C (en) * 1987-02-03 1994-08-09 Dow Corning Corporation Aqueous film-forming compositions for controlling the release of active agents and process of making same
FR2610827B1 (fr) * 1987-02-18 1991-09-13 Pf Medicament Comprime de dihydroergotamine (d.h.e.) du type a matrice hydrophile et son procede de fabrication
GB8704755D0 (en) * 1987-02-28 1987-04-01 Dow Corning Ltd Pharmaceutical delivery device

Also Published As

Publication number Publication date
EP0425154B1 (en) 1993-09-15
HU906525D0 (en) 1991-04-29
IE903777A1 (en) 1991-04-24
DE69003347T2 (de) 1994-02-17
KR910007518A (ko) 1991-05-30
FI905195A0 (fi) 1990-10-22
IE66826B1 (en) 1996-02-07
CA2027865A1 (en) 1991-04-24
FR2653337B1 (fr) 1992-02-07
ES2044451T3 (es) 1994-01-01
AU639947B2 (en) 1993-08-12
JPH03167116A (ja) 1991-07-19
HUT69395A (en) 1995-09-28
AU6486390A (en) 1991-04-26
BR9005223A (pt) 1991-09-17
DE69003347D1 (de) 1993-10-21
EP0425154A1 (en) 1991-05-02
FR2653337A1 (fr) 1991-04-26

Similar Documents

Publication Publication Date Title
DK0425154T3 (da) Genstande med vedvarende afgivelse af aktivt stof
DK0383569T3 (da) Opbevaring af materialer
KR920011223U (ko) 1회용 착용물품
DK392281A (da) Pestcide midler med langsom frigorelse af den aktive bestanddel
DK230789A (da) Fremgangsmaade til fremstilling af cytidinderivater
DK324385A (da) Farmaceutisk praeparat med kontrolleret frigivelse af det aktive stof
LV10086A (lv) CIV - inhibejosi benzolacetamida atvasinajumi
DE69122183T2 (de) Leicht und schnell prüfbare Master-Slave-Kippschaltung
DK386986A (da) Injicerbar halvfast farmaceutisk formulering med langsom frigivelse af den aktive bestanddel
DK372089A (da) Anvendelse af isoquinolinderivater
DK73980A (da) Insecticidt eller nematodicidt granulat med forhalet frigoerelse af den aktive bestanddel
DK104389D0 (da) Anvendelse af imidazolderivater
DK592488D0 (da) Fremgangsmaade til fremstilling af formstabile genstande
DK130390A (da) Praeparat af i prokaryonter udtrykt plasminogenaktivator
DK104489D0 (da) Anvendelse af triazolderivater
DK283990D0 (da) Indretning til chargevis tilberedning af styrtgods
NO900009D0 (no) Fremgangsmaate for fremstilling av aspiringranuler med regulert frigivningseffekt.
DK562289D0 (da) Anvendelse af somatostatiner
DK229789A (da) Farmaceutiske oploesninger af triamteren
DK326789A (da) Fremstilling af homonojirimycin-derivater
KR940002728U (ko) 의복에 부착되는 찜질팩
DK0402857T3 (da) Anvendelse af 17beta-cyclopropylamino-androsten-derivater
KR920005963U (ko) 1회용 착용 물품
DK98389A (da) Formuleringer af liposomale antineoplastiske midler med hoeje medikament-lipid-forhold
IT9036120V0 (it) Struttura di pantaloni perfezionata